Neocartilage formation from mesenchymal stem cells grown in type II collagen-hyaluronan composite scaffolds

Differentiation

Volumn 86, Issue 4-5, 2013, Pages 171-183

  Yeh, Hsi Yi ^a   Lin, Ting Yu ^a   Lin, Chen Huan ^b   Yen, B Linju ^c   Tsai, Ching Lin ^d   Hsu, Shan hui ^a,e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Chondrocytes; Hyaluronic acid (HA); Mesenchymal stem cells (MSCs); Neocartilage; Small intestinal submucosa (SIS); Type II collagen

Indexed keywords

AGGRECAN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGEN TYPE II HYALURONAN COMPOSITE SCAFFOLD; GLYCOSAMINOGLYCAN; HYALURONIC ACID; MOLECULAR SCAFFOLD; POLYSTYRENE DERIVATIVE; TISSUE CULTURE POLYSTYRENE; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ADIPOSE DERIVED ADULT STEM CELL; ADULT STEM CELL; AGGRECAN GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELLULAR DISTRIBUTION; CHONDROGENESIS; COLLAGEN TYPE II GENE; COMPARATIVE EFFECTIVENESS; COMPRESSION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FLOW KINETICS; GENE EXPRESSION REGULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOLECULAR STABILITY; MOUSE; MULTIPOTENT STEM CELL; NEOCARTILAGE; NOD SCID MOUSE; NONHUMAN; PLACENTA DERIVED MULTIPOTENT CELL; PRIORITY JOURNAL; SMALL INTESTINE SUBMUCOSA SHEET; SOX9 GENE; SWINE; TISSUE ENGINEERING; UPREGULATION; ADULT; ANIMAL; CHEMISTRY; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; MESENCHYMAL STROMA CELL; METABOLISM; PREGNANCY; TISSUE SCAFFOLD;

MUS; SUS;

ADULT; ANIMALS; CARTILAGE; CELL DIFFERENTIATION; CHONDROGENESIS; COLLAGEN TYPE II; FEMALE; HUMANS; HYALURONIC ACID; MESENCHYMAL STROMAL CELLS; MICE; PREGNANCY; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84899048542     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2013.11.001     Document Type: Article

References (52)

1. Allemann F., Mizuno S., Eid K., Yates K.E., Zaleske D., Glowacki J. Effects of hyaluronan on engineered articular cartilage extracellular matrix gene expression in 3-dimensional collagen scaffolds. J. Biomed. Mater. Res. 2001, 55:13-19.
2. Allison D.D., Grande-Allen K.J. Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng. 2006, 12:2131-2140.
3. Avwioro G. Histochemical uses of haematoxylin-A review. J. Pharm. Clin. Sci. 2011, 1:5.
4. Bernardo M.E., Emons J.A., Karperien M., Nauta A.J., Willemze R., Roelofs H., Romeo S., Marchini A., Rappold G.A., Vukicevic S., Locatelli F., Fibbe W.E. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect. Tissue Res. 2007, 48:132-140.
5. Cao H., Xu S.Y. EDC/NHS-crosslinked type II collagen-chondroitin sulfate scaffold: characterization and in vitro evaluation. J. Mater. Sci. Mater. Med. 2008, 19:567-575.
6. Chang C.J., Yen M.L., Chen Y.C., Chien C.C., Huang H.I., Bai C.H., Yen B.L. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 2006, 24:2466-2477.
7. Chang J.C., Su H.L., Hsu S.H. The use of peptide-delivery to protect human adipose-derived adult stem cells from damage caused by the internalization of quantum dots. Biomaterials 2008, 29:925-936.
8. Cavallo C., Cuomo C., Fantini S., Ricci F., Tazzari P.L., Lucarelli E., Donati D., Facchini A., Lisignoli G., Fornasari P.M., Grigolo B., Moroni L. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. J. Cell. Biochem. 2011, 112:1418-1430.
9. Crapo P.M., Wang Y.D. Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering. Acta Biomater. 2010, 6:2091-2096.
10. Evanko S.P., Tammi M.I., Tammi R.H., Wight T.N. Hyaluronan-dependent pericellular matrix. Adv. Drug Deliv. Rev. 2007, 59:1351-1365.
11. Fournier B.P., Ferre F.C., Couty L., Lataillade J.J., Gourven M., Naveau A., Coulomb B., Lafont A., Gogly B. Multipotent progenitor cells in gingival connective tissue. Tissue Eng. Part A 2010, 16:2891-2899.
12. Goodstone N.J., Alison C., Ashton B. Effects of high molecular weight hyaluronan on chondrocytes cultured within a resorbable gelatin sponge. Tissue Eng. 2004, 10:621-631.
13. Garcia-Fuentes M., Meinel A.J., Hilbe M., Meinel L., Merkle H.P. Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials 2009, 30:5068-5076.
14. Hsu S.H., Huang G.S., Feng F. Isolation of the multipotent MSC subpopulation from human gingival fibroblasts by culturing on chitosan membranes. Biomaterials 2012, 33:2642-2655.
15. Hsu S.H., Huang T.B., Cheng S.J., Weng S.Y., Tsai C.L., Tseng C.S., Chen D.C., Liu T.Y., Fu K.Y., Yen B.L. Chondrogenesis from human placenta-derived mesenchymal stem cells in three-dimensional scaffolds for cartilage tissue engineering. Tissue Eng. Part A 2011, 17:1549-1560.
16. Huang G.S., Dai L.G., Yen B.L., Hsu S.H. Spheroid formation of mesenchymal stem cells on chitosan and chitosan-hyaluronan membranes. Biomaterials 2011, 32:6929-6945.
17. Huey D.J., Hu J.C., Athanasiou K.A. Unlike bone, cartilage regeneration remains elusive. Science 2012, 338:917-921.
18. Kim K.S., Lee J.Y., Kang Y.M., Kim E.S., Kim G.H., Rhee S.D., Cheon H.G., Kim J.H., Min B.H., Lee H.B., Kim M.S. Small intestine submucosa sponge for in vivo support of tissue-engineered bone formation in the presence of rat bone marrow stem cells. Biomaterials 2010, 31:1104-1113.
19. Laurent T.C., Fraser J.R. Hyaluronan-Faseb J. 1992, 6:2397-2404.
20. Li F., Chen Y.Z., Miao Z.N., Zheng S.Y., Jin J. Human placenta-derived mesenchymal stem cells with silk fibroin biomaterial in the repair of articular cartilage defects. Cell. Reprogram. 2012, 14:334-341.
21. Liu D., Hui H., Chai X., Wang B., Qiu J. Construction of tissue-engineered cartilage using human placenta-derived stem cells. Sci. China Life Sci. 2010, 53:207-214.
22. Liu L.S., Thompson A.Y., Heidaran M.A., Poser J.W., Spiro R.C. An osteoconductive collagen/hyaluronate matrix for bone regeneration. Biomaterials 1999, 20:1097-1108.
23. Longo U.G., Loppini M., Berton A., La Verde L., Khan W.S., Denaro V. Stem cells from umbilical cord and placenta for musculoskeletal tissue engineering. Curr. Stem Cell Res. Ther. 2012, 7:272-281.
24. Lu Z., Doulabi B.Z., Huang C., Bank R.A., Helder M.N. Collagen type II enhances chondrogenesis in adipose tissue-derived stem cells by affecting cell shape. Tissue Eng. Part A 2010, 16:81-90.
25. Ma L., Gao C., Mao Z., Zhou J., Shen J., Hu X., Han C. Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials 2003, 24:4833-4841.
26. Maroudas A. Physiochemical properties of articular cartilage. Adult Articular Cartilage 1979, 215-290. Pitman Medical, Kent, England. 2nd edition. M.A.R. Freeman (Ed.).
27. Matikainen T., Laine J. Placenta-an alternative source of stem cells. Toxicol. Appl. Pharmacol. 2005, 207:544-549.
28. Mitrano T.I., Grob M.S., Carrion F., Nova-Lamperti E., Luz P.A., Fierro F.S., Quintero A., Chaparro A., Sanz A. Culture and characterization of mesenchymal stem cells from human gingival tissue. J. Periodontol. 2010, 81:917-925.
29. Montesinos J.J., Flores-Figueroa E., Castillo-Medina S., Flores-Guzman P., Hernandez-Estevez E., Fajardo-Orduna G., Orozco S., Mayani H. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Cytotherapy 2009, 11:163-176.
30. Mueller S.M., Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J. Cell. Biochem. 2001, 82:583-590.
31. Nehrer S., Breinan H.A., Ramappa A., Shortkroff S., Young G., Minas T., Sledge C.B., Yannas I.V., Spector M. Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. J. Biomed. Mater. Res. 1997, 38:95-104.
32. Park S.N., Kim J.K., Suh H. Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute. Biomaterials 2004, 25:3689-3698.
33. Park S.N., Park J.C., Kim H.O., Song M.J., Suh H. Characterization of porous collagen/hyaluronic acid scaffold modified by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide cross-linking. Biomaterials 2002, 23:1205-1212.
34. Pieper J.S., Hafmans T., Veerkamp J.H., van Kuppevelt T.H. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials 2000, 21:581-593.
35. Pietrucha K. Changes in denaturation and rheological properties of collagen-hyaluronic acid scaffolds as a result of temperature dependencies. Int. J. Biol. Macromol. 2005, 36:299-304.
36. Pittenger M.F., Mackay A.M., Beck S.C. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
37. Schuh E., Hofmann S., Stok K.S., Notbohm H., Müller R., Rotter N. The influence of matrix elasticity on chondrocyte behavior in 3D. J. Tissue Eng. Regen. Med. 2012, 6:e31-e42.
38. Schuh E., Hofmann S., Stok K.S., Notbohm H., Müller R., Rotter N. Chondrocyte redifferentiation in 3D: the effect of adhesion site density and substrate elasticity. J. Biomed. Mater. Res. A 2011, 100:38-47.
39. Seda Tigli R., Ghosh S., Laha M.M., Shevde N.K., Daheron L., Gimble J., Gümüşderelioglu M., Kaplan D.L. Comparative chondrogenesis of human cell sources in 3D scaffolds. J. Tissue Eng. Regen. Med. 2009, 3:348-360.
40. Shainer R., Gaberman E., Levdansky L., Gorodetsky R. Efficient isolation and chondrogenic differentiation of adult mesenchymal stem cells with fibrin microbeads and micronized collagen sponges. Regen. Med. 2010, 5:255-265.
41. Stoddart M.J., Grad S., Eglin D., Alini M. Cells and biomaterials in cartilage tissue engineering. Regen. Med. 2009, 4:81-98.
42. Taguchi T., Ikoma T., Tanaka J. An improved method to prepare hyaluronic acid and type II collagen composite matrices. J. Biomed. Mater. Res. 2002, 61:330-336.
43. Tan W., Krishnaraj R., Desai T.A. Evaluation of nanostructured composite collagen-chitosan matrices for tissue engineering. Tissue Eng. 2001, 7:203-210.
44. Tang S., Spector M. Incorporation of hyaluronic acid into collagen scaffolds for the control of chondrocyte-mediated contraction and chondrogenesis. Biomed. Mater. 2007, 2:135-141.
45. Toole B.P. Hyaluronan in morphogenesis. Semin. Cell Dev. Biol. 2001, 12:79-87.
46. Veilleux N.H., Yannas I.V., Spector M. Effect of passage number and collagen type on the proliferative, biosynthetic, and contractile activity of adult canine articular chondrocytes in type I and II collagen-glycosaminoglycan matrices in vitro. Tissue Eng. 2004, 10:119-127.
47. Wu S.C., Chang J.K., Wang C.K., Wang G.J., Ho M.L. Enhancement of chondrogenesis of human adipose derived stem cells in a hyaluronan-enriched microenvironment. Biomaterials 2010, 31:631-640.
48. Yamane S., Iwasaki N., Majima T., Funakoshi T., Masuko T., Harada K., Minami A., Monde K., Nishimura S. Feasibility of chitosan-based hyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue engineering. Biomaterials 2005, 26:611-619.
49. Yang Y.L., Kaufman L.J. Rheology and confocal reflectance microscopy as probes of mechanical properties and structure during collagen and collagen/hyaluronan self-assembly. Biophys. J. 2009, 96:1566-1585.
50. Yoo H.S., Lee E.A., Yoon J.J., Park T.G. Hyaluronic acid modified biodegradable scaffolds for cartilage tissue engineering. Biomaterials 2005, 26:1925-1933.
51. Zhang X., Mitsuru A., Igura K., Takahashi K., Ichinose S., Yamaquchi S., Takahashi T.A. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem. Biophys. Res. Commun. 2006, 340:944-952.
52. Zhang Y.Y., McNeill E., Tian H., Soker S., Andersson K.E., Yoo J.J., Atala A. Urine derived cells are a potential source for urological tissue reconstruction. J. Urol. 2008, 180:2226-2233.